Review Article
Theranostic nanomedicine for cancer detection and treatment

https://doi.org/10.1016/j.jfda.2014.01.001Get rights and content
Under an Elsevier user license
open archive

Abstract

Cancer is the second leading cause of death in the USA according to the American Cancer Society. In the past 5 years, “theranostic nanomedicine”, for both therapeutics and imaging, has shown to be “the right drug for the right patient at the right moment” to manage deadly cancers. This review article presents an overview of recent developments, mainly from the authors' laboratories, along with potential medical applications for theranostic nanomedicine including basic concepts and critical properties. Finally, we outline the future research direction and possible challenges for theranostic nanomedicine research.

Keywords

Circulating tumor cell diagnosis
Combined therapy
Photothermal therapy
Selective cancer treatment
Theranostic nanomedicine

Cited by (0)

This article is not an official FDA guidance or policy statement. No official support or endorsement by the FDA is intended or should be inferred.